| Nome |
# |
|
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis, file e2913fdf-8ccc-f688-e053-3705fe0a67e0
|
435
|
|
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome, file e2913fda-c031-f688-e053-3705fe0a67e0
|
294
|
|
Pharmacogenetics of thiopurines, file e2913fdc-94d6-f688-e053-3705fe0a67e0
|
268
|
|
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients, file e2913fdf-1fff-f688-e053-3705fe0a67e0
|
216
|
|
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease, file e2913fdf-5396-f688-e053-3705fe0a67e0
|
209
|
|
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients, file e2913fdc-38a0-f688-e053-3705fe0a67e0
|
202
|
|
Pharmacogenetics of treatments for inflammatory bowel disease, file e2913fdf-50a2-f688-e053-3705fe0a67e0
|
198
|
|
Effects of Two Fullerene Derivatives on Monocytes and Macrophages, file e2913fd9-6887-f688-e053-3705fe0a67e0
|
187
|
|
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events, file e2913fdd-4032-f688-e053-3705fe0a67e0
|
171
|
|
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay, file e2913fdb-91a9-f688-e053-3705fe0a67e0
|
162
|
|
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia, file e2913fdc-9ee2-f688-e053-3705fe0a67e0
|
158
|
|
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants, file e2913fdc-9ee7-f688-e053-3705fe0a67e0
|
151
|
|
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance, file e2913fda-82e3-f688-e053-3705fe0a67e0
|
147
|
|
Pharmacogenomics of antibiotics, file e2913fdd-ad8a-f688-e053-3705fe0a67e0
|
104
|
|
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency, file e2913fdf-2ba6-f688-e053-3705fe0a67e0
|
90
|
|
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis, file e2913fda-838a-f688-e053-3705fe0a67e0
|
86
|
|
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response, file e2913fd9-7b4f-f688-e053-3705fe0a67e0
|
82
|
|
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells, file e2913fdf-9bb9-f688-e053-3705fe0a67e0
|
77
|
|
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention, file e2913fde-da00-f688-e053-3705fe0a67e0
|
76
|
|
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs, file 1594398c-8708-47df-9543-6c4c134afa07
|
67
|
|
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease, file e2913fde-cc2b-f688-e053-3705fe0a67e0
|
60
|
|
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway, file e2913fdd-ad88-f688-e053-3705fe0a67e0
|
46
|
|
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease, file 3844bc76-eee8-4b84-a647-ccd1f3bf519d
|
43
|
|
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis, file e2913fd9-a698-f688-e053-3705fe0a67e0
|
43
|
|
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients, file e2913fdd-70c2-f688-e053-3705fe0a67e0
|
43
|
|
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease, file e2913fde-b6f3-f688-e053-3705fe0a67e0
|
38
|
|
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease, file c6a99495-ea4d-487c-88ba-7d779a167f9f
|
37
|
|
Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa, file e2913fde-c5b9-f688-e053-3705fe0a67e0
|
37
|
|
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD, file e2913fdd-0e50-f688-e053-3705fe0a67e0
|
36
|
|
Patient-derived organoids for therapy personalization in inflammatory bowel diseases, file 42c7286d-1ed8-4321-b309-c88fe406c27a
|
35
|
|
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway, file e2913fdd-9822-f688-e053-3705fe0a67e0
|
34
|
|
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD, file e2913fdd-1e15-f688-e053-3705fe0a67e0
|
33
|
|
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease, file e2913fdd-11a4-f688-e053-3705fe0a67e0
|
32
|
|
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells, file 2e82488e-c700-478b-af42-150283fa6632
|
27
|
|
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study, file e2913fdf-9c5e-f688-e053-3705fe0a67e0
|
27
|
|
Microbiota and drug response in inflammatory bowel disease, file e2913fde-581a-f688-e053-3705fe0a67e0
|
25
|
|
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease, file e2913fde-b6f1-f688-e053-3705fe0a67e0
|
14
|
|
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells, file 1823a521-90f3-426e-a485-b4410e18f9f3
|
12
|
|
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response, file e2913fd9-2b24-f688-e053-3705fe0a67e0
|
12
|
|
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease, file e2913fde-d5b4-f688-e053-3705fe0a67e0
|
12
|
|
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside, file 72024c06-f5bb-488e-9044-c6220f805314
|
11
|
|
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study, file e2913fdc-8a25-f688-e053-3705fe0a67e0
|
10
|
|
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease, file e2913fdc-a772-f688-e053-3705fe0a67e0
|
10
|
|
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients, file e2913fde-8ebc-f688-e053-3705fe0a67e0
|
10
|
|
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease, file 28c715ea-8bcf-482a-ab4b-a1aafd2dd2b6
|
8
|
|
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis, file e2913fdd-97cc-f688-e053-3705fe0a67e0
|
8
|
|
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients, file e2913fde-d2a7-f688-e053-3705fe0a67e0
|
7
|
|
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis, file e2913fda-86eb-f688-e053-3705fe0a67e0
|
6
|
|
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis, file e2913fdd-828f-f688-e053-3705fe0a67e0
|
6
|
|
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia, file e2913fdd-b388-f688-e053-3705fe0a67e0
|
6
|
|
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report, file 0fa973ce-4f95-4342-a055-8c83a3ccdacd
|
5
|
|
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome, file e2913fda-bb54-f688-e053-3705fe0a67e0
|
5
|
|
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease, file e2913fdb-c79f-f688-e053-3705fe0a67e0
|
5
|
|
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency, file e2913fdd-ae17-f688-e053-3705fe0a67e0
|
5
|
|
Pharmacogenetics of treatments for inflammatory bowel disease, file e2913fde-6ae3-f688-e053-3705fe0a67e0
|
5
|
|
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study, file 023bda0d-c8a5-474f-ac0e-050373bb39af
|
4
|
|
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs, file 22093a18-79a6-4f81-b78c-d78d531f0f1f
|
4
|
|
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity, file e2913fd9-44f2-f688-e053-3705fe0a67e0
|
4
|
|
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance, file e2913fda-8124-f688-e053-3705fe0a67e0
|
4
|
|
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients, file e2913fdd-010a-f688-e053-3705fe0a67e0
|
4
|
|
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs, file 9e832f1e-f701-40b0-ad44-07bda0dcc947
|
3
|
|
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A, file e2913fd9-a568-f688-e053-3705fe0a67e0
|
3
|
|
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5, file e2913fda-cf52-f688-e053-3705fe0a67e0
|
3
|
|
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome, file e2913fdd-1e1a-f688-e053-3705fe0a67e0
|
3
|
|
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles., file e2913fd9-16ee-f688-e053-3705fe0a67e0
|
2
|
|
Pro-inflammatory effects of palytoxin: An: in vitro study on human keratinocytes and inflammatory cells, file e2913fda-be7e-f688-e053-3705fe0a67e0
|
2
|
|
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay, file e2913fdb-9306-f688-e053-3705fe0a67e0
|
2
|
|
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor, file e2913fdc-378f-f688-e053-3705fe0a67e0
|
2
|
|
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor, file e2913fdc-3d29-f688-e053-3705fe0a67e0
|
2
|
|
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients, file e2913fdd-61ed-f688-e053-3705fe0a67e0
|
2
|
|
A patent review of anticancer glucocorticoid receptor modulators (2014-present), file e2913fdd-a86d-f688-e053-3705fe0a67e0
|
2
|
|
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients, file e2913fdd-ac61-f688-e053-3705fe0a67e0
|
2
|
|
Clinical application of thiopurine pharmacogenomics in pediatrics, file e2913fdd-ac63-f688-e053-3705fe0a67e0
|
2
|
|
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells, file e2913fde-ae7b-f688-e053-3705fe0a67e0
|
2
|
|
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook, file e2913fde-eb7f-f688-e053-3705fe0a67e0
|
2
|
|
iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy, file 2e74d748-814a-4a44-abfa-040e3070b469
|
1
|
|
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5, file a0db96c4-3dbd-4b64-919b-53013f4a2eb7
|
1
|
|
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells, file e2913fd9-1c70-f688-e053-3705fe0a67e0
|
1
|
|
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease, file e2913fda-a034-f688-e053-3705fe0a67e0
|
1
|
|
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort, file e2913fdb-c9a5-f688-e053-3705fe0a67e0
|
1
|
|
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease, file e2913fdc-35ce-f688-e053-3705fe0a67e0
|
1
|
|
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY, file e2913fdc-99d2-f688-e053-3705fe0a67e0
|
1
|
|
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome, file e2913fdc-e779-f688-e053-3705fe0a67e0
|
1
|
|
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease, file e2913fdc-e8d8-f688-e053-3705fe0a67e0
|
1
|
|
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome, file e2913fdc-eff4-f688-e053-3705fe0a67e0
|
1
|
|
Sedation and analgesia in children with cerebral palsy: a narrative review, file e2913fdd-4268-f688-e053-3705fe0a67e0
|
1
|
|
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook, file e2913fdf-1b2e-f688-e053-3705fe0a67e0
|
1
|
| Totale |
4.199 |